Fludarabine/Rituximab Combined With Escalating Doses of Lenalidomide in Untreated CLL
Clinical trial NCT01703364 · COMPLETED
Trial details
- NCT number
- NCT01703364
- Sponsor
- Arbeitsgemeinschaft medikamentoese Tumortherapie
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2015-03-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.